Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Bussink

Showing results (91-100 of 220) with videos related to

Pageof 22
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2013
Imaging of epidermal growth factor receptor expression in head and neck cancer with SPECT/CT and 111In-labeled cetuximab-F(ab')2Laura K van Dijk, Bianca A W Hoeben, Johannes H A M Kaanders, et al.
Plos One|September 17, 2014
Tumor microenvironmental changes induced by the sulfamate carbonic anhydrase IX inhibitor S4 in a laryngeal tumor modelTineke W H Meijer, Johan Bussink, Miriam Zatovicova, et al.
Head & Neck|March 18, 2014
Hypoxic regulation of the PERK/ATF4/LAMP3-arm of the unfolded protein response in head and neck squamous cell carcinomaAnika Nagelkerke, Fred C G J Sweep, Hanneke Stegeman, et al.
Radiation Oncology (London, England)|May 25, 2012
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancerKathrine Røe, Lars Tg Mikalsen, Albert J van der Kogel, et al.
Biomarkers in Medicine|March 27, 2015
Poor prognosis of constitutive γ-H2AX expressing triple-negative breast cancers is associated with telomere lengthAnika Nagelkerke, Simon J A van Kuijk, John W Martens, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 20, 2025
Impact of patient characteristics on primary treatment approach of endometrial cancer: a population-based study in the NetherlandsHeidi Rütten, Hans H B Wenzel, Mieke Ten Eikelder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2018
Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast CancerAnnemarie E M Post, Marcel Smid, Anika Nagelkerke, et al.
Nuclear Medicine Communications|October 7, 2015
Evaluating the use of optimally respiratory gated 18F-FDG-PET in target volume delineation and its influence on radiation doses to the organs at risk in non-small-cell lung cancer patientsRobin Wijsman, Willem Grootjans, Esther G Troost, et al.
Cancer|February 15, 2011
Hypoxic regulation and prognostic value of LAMP3 expression in breast cancerAnika Nagelkerke, Hilda Mujcic, Johan Bussink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Correlation of segmented metabolic tumor volume with outcome--letterEsther G C Troost, Dominic A X Schinagl, Johan Bussink, et al.
Pageof 22

Showing results (91-100 of 220) with videos related to

Sort By:
Pageof 22
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2013
Imaging of epidermal growth factor receptor expression in head and neck cancer with SPECT/CT and 111In-labeled cetuximab-F(ab')2Laura K van Dijk, Bianca A W Hoeben, Johannes H A M Kaanders, et al.
Plos One|September 17, 2014
Tumor microenvironmental changes induced by the sulfamate carbonic anhydrase IX inhibitor S4 in a laryngeal tumor modelTineke W H Meijer, Johan Bussink, Miriam Zatovicova, et al.
Head & Neck|March 18, 2014
Hypoxic regulation of the PERK/ATF4/LAMP3-arm of the unfolded protein response in head and neck squamous cell carcinomaAnika Nagelkerke, Fred C G J Sweep, Hanneke Stegeman, et al.
Radiation Oncology (London, England)|May 25, 2012
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancerKathrine Røe, Lars Tg Mikalsen, Albert J van der Kogel, et al.
Biomarkers in Medicine|March 27, 2015
Poor prognosis of constitutive γ-H2AX expressing triple-negative breast cancers is associated with telomere lengthAnika Nagelkerke, Simon J A van Kuijk, John W Martens, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 20, 2025
Impact of patient characteristics on primary treatment approach of endometrial cancer: a population-based study in the NetherlandsHeidi Rütten, Hans H B Wenzel, Mieke Ten Eikelder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2018
Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast CancerAnnemarie E M Post, Marcel Smid, Anika Nagelkerke, et al.
Nuclear Medicine Communications|October 7, 2015
Evaluating the use of optimally respiratory gated 18F-FDG-PET in target volume delineation and its influence on radiation doses to the organs at risk in non-small-cell lung cancer patientsRobin Wijsman, Willem Grootjans, Esther G Troost, et al.
Cancer|February 15, 2011
Hypoxic regulation and prognostic value of LAMP3 expression in breast cancerAnika Nagelkerke, Hilda Mujcic, Johan Bussink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Correlation of segmented metabolic tumor volume with outcome--letterEsther G C Troost, Dominic A X Schinagl, Johan Bussink, et al.
Pageof 22